2-26482516-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_194248.3(OTOF):c.1469C>G(p.Pro490Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,613,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_194248.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.1469C>G | p.Pro490Arg | missense_variant | Exon 14 of 47 | 1 | NM_194248.3 | ENSP00000272371.2 | ||
OTOF | ENST00000403946.7 | c.1469C>G | p.Pro490Arg | missense_variant | Exon 14 of 46 | 5 | ENSP00000385255.3 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250848Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135820
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460814Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 726696
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 490 of the OTOF protein (p.Pro490Arg). This variant is present in population databases (rs80356585, gnomAD 0.004%). This missense change has been observed in individuals with auditory neuropathy spectrum disorder and/or deafness (PMID: 27652356, 33426078, 33908410, 34424407). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 48170). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on OTOF protein function. For these reasons, this variant has been classified as Pathogenic. -
Observed with a second OTOF variant in unrelated patients with hearing loss in published literature (PMID: 33426078, 33908410); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 37677959, 33426078, 33908410, 27652356, 34424407) -
OTOF-related disorder Pathogenic:1
The OTOF c.1469C>G variant is predicted to result in the amino acid substitution p.Pro490Arg. This variant has been reported in the homozygous or compound heterozygous state in individuals with auditory neuropathy (Al-Wardy et al. 2016. PubMed ID: 27652356; Zhai et al. 2020. PubMed ID: 33426078; Table S1A, Thorpe et al. 2021. PubMed ID: 34424407). Of note, another variant impacting the same amino acid (p.Pro490Gln) was reported in cis with another variant in OTOF (p.Ile515Thr), both in the homozygous state in four individuals from the same family, all with nonsyndromic autosomal recessive deafness (Mirghomizadeh et al. 2002. PubMed ID: 12127154). This variant is reported in 0.0044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. -
Nonsyndromic genetic hearing loss Pathogenic:1
Variant summary: OTOF c.1469C>G (p.Pro490Arg) results in a non-conservative amino acid change located in the C2 domain (IPR000008) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 250848 control chromosomes (gnomAD). c.1469C>G has been reported in the literature as a biallelic genotype in multiple individuals affected with Nonsyndromic Hearing Loss And Deafness, including at least one family in which it segregated with the disease phenotype (e.g. Al-Wardy_2016, Zhai_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The Pro490Arg i n OTOF variant has not been reported in the literature nor previously reported i n the laboratory. This residue is conserved across species and computational ana lyses (biochemical amino acid properties, homology, PolyPhen2, SIFT) suggest tha t the Pro490Arg variant may impact the protein. However, this information is not predictive enough to assume pathogenicity. Another variant at the same codon (P ro490Gln) has been reported in one Turkish family with profound hearing loss; ho wever, this variant was observed in cis with a second OTOF missense variant of u nknown significance in that family (Mighomizadeh 2002). The presence of this var iant in combination with a reported pathogenic variant and in this individual wh o has auditory neuropathy, increases the likelihood that the Pro490Arg variant i s pathogenic. In summary, the clinical significance of this variant cannot be de termined at this time; however, based upon the arguments described above, we wou ld lean towards a more likely pathogenic role. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at